Adhesion
Zyxin Antibody
|
イイネ!(0)
|
|
| CSTコード |
包装 |
希望納入価格 (円) |
国内在庫  |
ご登録代理店情報  カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更は こちら。 |
| #3553S | 100 μL | 46,000 | |
|
Zyxin抗体製品一覧
3553 の推奨プロトコール
最適な結果を得るために:Cell Signaling Technology (CST) 社は、各製品の推奨プロトコールを使用することを強くお薦めいたします。
推奨プロトコールはCST社内試験の徹底的なバリデーションに基づいて作成されておりますので、正確かつ再現性の高い結果が得られます。
注:各製品に最適化されたプロトコールをリンクしています。
| | |
-
3553:
-
Western Blotting
| 用途 (希釈倍率) | |
| ウェスタンブロッティング (1:1,000) |
| 特異性・感度 | |
| 内在性レベルのZyxin タンパク質を検出します。 |
| 使用抗原 | |
| ヒトのZyxin タンパク質の中央領域 (合成リン酸化ペプチド) |
Western Blotting

Western blot analysis of extracts from various cell lines using Zyxin Antibody.
The Ras superfamily of small GTP-binding proteins (G proteins) comprise a large class of proteins (over 150 members) that can be classified into at least five families based on their sequence and functional similarities: Ras, Rho, Rab, Arf, and Ran (1,2,3). All these small G proteins have both GDP/GTP-binding and GTPase activities and function as binary switches in diverse cellular and developmental events that include cell cycle preogression, cell survival, actin cytoskeletal organization, cell polarity and movement, and vesicular and nuclear transport (1). An upstream signal stimulates the dissociation of GDP from the GDP-bound form (inactive), which leads to the binding of GTP and entering the GTP-bound form (active). The activated GTP-bound form then goes through conformational change in the its downstream effector-binding region, eventually leads to binding and function regulation of downstream effectors. This activation can be switched off by the intrinsic GTPase activity, which hydrolyzes GTP to GDP and release the downstream effectors. These intrinsic guanine nucleotide exchange and GTP hydrolysis activities of Ras superfamily proteins are also regulated by guanine nucleotide exchange factors (GEFs) that promote formation of the active GTP-bound form and GTPase activating proteins (GAPs) that return the GTPase to its GDP-bound inactive form (4).
-
Takai, Y. et al. (2001) Physiol Rev 81, 153-208.
-
Colicelli, J. (2004) Sci STKE 2004, RE13.
-
Wennerberg, K. et al. (2005) J Cell Sci 118, 843-6.
-
Vigil, D. et al. (2010) Nat Rev Cancer 10, 842-57.